Skip to main content

Clonazepam

ADVERTISEMENT
Identification
Molecular formula
C15H10ClFN2O3
CAS number
1622-61-3
IUPAC name
7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-3H-1,4-benzodiazepin-2-one
State
State

At room temperature, clonazepam is typically in a solid state in the form of a crystalline powder. It can also be pressed and formulated into tablet form for medicinal use, instead of being in its pure powder form.

Melting point (Celsius)
230.00
Melting point (Kelvin)
503.20
Boiling point (Celsius)
555.60
Boiling point (Kelvin)
828.80
General information
Molecular weight
315.72g/mol
Molar mass
315.7150g/mol
Density
1.3100g/cm3
Appearence

Clonazepam typically appears as a white to light yellow crystalline powder. It is odorless and has a bitter taste. In its pure form, it is usually handled in powder form for pharmaceutical manufacturing. The powder consistency may vary slightly depending on purity and processing methods.

Comment on solubility

Solubility of 7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-3H-1,4-benzodiazepin-2-one

The solubility of 7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-3H-1,4-benzodiazepin-2-one is influenced by its structural characteristics. This compound features a benzodiazepine core with various substituents that can affect its interaction with solvents.

In general, the solubility of such organic compounds can be categorized based on a few key factors:

  • Polarity: The presence of hydroxyl groups generally increases solubility in polar solvents like water.
  • Hydrogen bonding: The compound’s ability to form hydrogen bonds can significantly enhance solubility in aqueous environments.
  • Functional groups: The presence of halogens and aromatic structures may influence overall solubility, as they can either stabilize or destabilize interactions with solvents.

It's essential to remember that the solubility may vary under different conditions, including:

  • Temperature: Increased temperature often enhances solubility.
  • pH: The pH of the solvent can affect the ionization state of the compound.

As a general observation, compounds within the benzodiazepine class can display moderate solubility in polar organic solvents while showing limited solubility in non-polar solvents. This makes careful consideration of solvent choice crucial during formulation and application.

In summary, the solubility of this benzodiazepine derivative is likely to be notable, particularly in polar environments, albeit subject to variations based on external factors.

Interesting facts

Interesting Facts about 7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-3H-1,4-benzodiazepin-2-one

The compound known as 7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-3H-1,4-benzodiazepin-2-one is a fascinating member of the benzodiazepine family, often recognized for its unique properties and potential applications in medicine.

Key Features

  • Mechanism of Action: This compound exhibits its effects primarily through interaction with the GABAA receptor, enhancing the inhibitory effects of GABA neurotransmitters. This mechanism is crucial for its anxiolytic and sedative properties.
  • Chemical Modifications: The presence of a chlorine atom and a fluorophenyl group introduces significant alterations in its biological activity compared to other benzodiazepines. Such modifications are often designed to enhance potency and selectivity.
  • Hydroxyethyl Group: The addition of a hydroxyethyl substituent is noteworthy as it may contribute to improved pharmacokinetic properties, such as solubility and distribution, which are vital for therapeutic efficacy.

Potential Applications

This compound's characteristics make it a subject of interest in pharmacological research, particularly for its potential use in treating:

  • Anxiety disorders
  • Insomnia
  • Seizure disorders

Research and Development

Observations have indicated that compounds like 7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-3H-1,4-benzodiazepin-2-one can also serve as scaffolds for drug development. The ability to modify different functional groups allows chemists to design derivatives that may have improved efficacy or reduced side effects.

Overall, this compound exemplifies the intricate balance between chemical structure and biological function, embodying the ongoing evolution of benzodiazepine-based therapies. Ongoing studies will likely unravel more about its full therapeutic potential.

Synonyms
20971-53-3
Ro-07-2750
N(sup 1)-(2-Hydroxyethyl)flurazepam
2Z6WHH283E
DTXSID10175152
DTXCID2097643
RefChem:883667
Ro 07-2750
2-Hydroxyethylflurazepam
2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-
N-1-(Hydroxyethyl)flurazepam
7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-3H-1,4-benzodiazepin-2-one
CHEMBL435684
Ro 7-2750
Flurazepam, hydroxyethyl
UNII-2Z6WHH283E
Flurazepam, (N-hydroxyethyl)-
SCHEMBL11679711
2-HYDROXY-ETHYLFLURAZEPAM
BDBM50408009
Ro-072750
PD212694
HY-168367
NS00003311
2-Hydroxyethylflurazepam, 1mg/ml in Methanol
2-Hydroxyethylflurazepam 0.1 mg/ml in Methanol
2-Hydroxyethylflurazepam 1.0 mg/ml in Methanol
Q27255842
7-chloro-1-(2-hydroxyethyl)-5-(2-fluorophenyl)-1,3-dihyrdo-2H-1,4-benzodiazepin-2-one
7-Chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
2H-1,4-BENZODIAZEPIN-2-ONE, 7-CHLORO-5-(2-FLUOROPHENYL)-1,3-DIHYDRO-1-(2-HYDROXYETHYL)-
2H-1,4-BENZODIAZEPIN-2-ONE, 7-CHLORO-5-(O-FLUOROPHENYL)-1,3-DIHYDRO-1-(2-HYDROXYETHYL)-
7-CHLORO-1-(2-HYDROXYETHYL)-5-(2'-FLUOROPHENYL)-1,3-DIHYDRO-2H-1,4-BENZODIAZEPIN-2-ONE
7-CHLORO-1-(2-HYDROXYETHYL)-5-(2-FLUOROPHENYL)-1,3-DIHYDRO-2H-1,4-BENZODIAZEPIN-2-ONE
7-CHLORO-1-(2-HYDROXYETHYL)-5-(2-FLUOROPHENYL)-1,3-DIHYDRO-3H-1,4-BENZODIAZEPIN-2-ONE
tert-Butyl(dimethyl)silyl (1-[tert-butyl(dimethyl)silyl]-5-([tert-butyl(dimethyl)silyl]oxy)-1H-indol-3-yl)acetate